Major AIDS Group Files Complaint Against Drug Giant in South Africa
January 30, 2003
"AIDS Healthcare Foundation, the largest AIDS organization in the United States today [Tuesday] filed a complaint with South Africa's Competition Commission against GlaxoSmithKline," the AHF said in a statement issued in Durban, South Africa. AHF filed the complaint over the company's drug pricing and AIDS policies in South Africa, which it described as "having a stranglehold on key AIDS drug patents" and exercising "unfettered monopoly pricing on these life-saving medications." AHF wants the commission, an independent body ensuring that companies compete fairly and do not abuse positions of power, to overturn GlaxoSmithKline's sole right of manufacturing drugs in the country. "The AHF's Competition Commission complaint seeks to obtain licensing and manufacturing concessions in South Africa for some of the medication which Glaxo has the exclusive right to market and sell in South Africa," it said.Adapted from:
Agence France Presse
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.